-
公开(公告)号:ZA966371B
公开(公告)日:1998-01-26
申请号:ZA966371
申请日:1996-07-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , RITER KURT , ZIERKE THOMAS
IPC: C07K1/12 , C07K5/06 , C07K1/02 , C07K5/078 , C07K5/08 , C07K5/083 , C07K5/10 , C07K5/103 , C07K7/06 , A61K , C07K
Abstract: PCT No. PCT/EP96/03073 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05162 PCT Pub. Date Feb. 13, 1997A process for preparing pentapeptides of the formula I where A and R1-R3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II where R1 and R2 have the abovementioned meanings, and eliminating the group -NR1R2 by hydrolysis where appropriate the peptide obtained in this way.
-
公开(公告)号:PL321159A1
公开(公告)日:1997-11-24
申请号:PL32115995
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:SI9520061A
公开(公告)日:1997-06-30
申请号:SI9520061
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:CA2237721A1
公开(公告)日:1997-06-26
申请号:CA2237721
申请日:1996-12-11
Applicant: BASF AG
Inventor: BUSCHMANN ERNST , KLING ANDREAS , LIETZ HELMUT , BARLOZZARI TERESA , HEGE HANS-GUENTHER , HAUPT ANDREAS , WEYMANN JUERGEN , JANSSEN BERND , ZIERKE THOMAS , RITTER KURT , BERNARD HARALD , ULLRICH MARTINA , AMBERG WILHELM
IPC: A61K38/00 , A61K31/00 , A61K38/08 , A61P35/00 , A61P35/02 , C07K1/00 , C07K7/06 , A61K38/07 , C07K5/103
Abstract: Novel peptides of the following formula (I): R1R2N-CHX-CO-A-B-D-E-(G)s-K in which R1, R2, A, B, D, E, G, K, X, and s have the meanings stated in the description, and the preparation thereof are described. The novel peptides have an antineoplastic effect.
-
公开(公告)号:HU9603068D0
公开(公告)日:1997-01-28
申请号:HU9603068
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , DE POTZOLLI BERND , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: Compounds of the formulawhere R1, R2, R3 and R4 have the meaning stated in the description, and a process for preparing them are described. The compounds are suitable as starting material for synthesizing substances which are active against tumors.
-
公开(公告)号:NO964688D0
公开(公告)日:1996-11-05
申请号:NO964688
申请日:1996-11-05
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MULLER STEFAN , POTZOLLI BERND DE , RITTER KURT , THYES MARCO , ZIERKE THOMAS
IPC: A61K38/08 , A61K38/00 , A61P35/00 , C07K1/08 , C07K5/10 , C07K5/103 , C07K7/06 , C07K14/52 , C07K
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:AU2408295A
公开(公告)日:1995-11-29
申请号:AU2408295
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MULLER STEFAN , POTZOLLI BERND DE , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: Compounds of the formulawhere R1, R2, R3 and R4 have the meaning stated in the description, and a process for preparing them are described. The compounds are suitable as starting material for synthesizing substances which are active against tumors.
-
公开(公告)号:DE59105281D1
公开(公告)日:1995-05-24
申请号:DE59105281
申请日:1991-11-21
Applicant: BASF AG
Inventor: SCHMIED BERNHARD , HOEFFKEN HANS , HORNBERGER WILFRIED , BERNARD HARALD
IPC: A61K38/55 , A61K38/00 , A61P7/02 , C07K7/06 , C07K14/815
Abstract: PCT No. PCT/EP91/02191 Sec. 371 Date Jul. 29, 1993 Sec. 102(e) Date Jul. 29, 1993 PCT Filed Nov. 21, 1991 PCT Pub. No. WO92/13879 PCT Pub. Date Aug. 20, 1992.Peptides of the formula where X, A1-A7 Y and W have the meanings stated in the description, and the preparation thereof are described. The peptides are suitable for controlling diseases.
-
公开(公告)号:CA2189690C
公开(公告)日:2007-06-19
申请号:CA2189690
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MULLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: Disclosed is the compound Me2Val-Val-MeVal-Pro-Pro-NHBzl. HCl. The compound is produced from Z-Val-Val-MeVal-Pro-OR1, wherein Z and R1 have the meanings indicated in the description. The compound disclosed has anti-neoplastic properties. >
-
公开(公告)号:CA2347758C
公开(公告)日:2004-09-21
申请号:CA2347758
申请日:1999-10-16
Applicant: BASF AG
Inventor: RIECHERS HARTMUT , BERNARD HARALD
Abstract: The invention relates to racemate splitting of 2-hydroxypropionic acids by reacting racemic acid with an optically active base and subsequently separating a diastereomeric salt from the acid and the base. Th e invention is characterized in that t-(4-chlorophenyl)ethylamine is used as optically active base.
-
-
-
-
-
-
-
-
-